Skip to main content
. 2016 Jun 14;7(29):46014–46027. doi: 10.18632/oncotarget.10014

Figure 5. Effect of CK2 inhibitor on expression of SH2B3 and IL7R.

Figure 5

A. The CK2 inhibitor, TBB, promotes SH2B3 but suppresses IL7R expression in B-ALL cells as assessed by q-PCR. B. CK2 knockdown promotes SH2B3 but suppresses IL7R expression in B-ALL cells by q-PCR. C. Ikaros knockdown rescues the TBB-induced change in SH2B3 and IL7R in B-ALL cells. Compared with siCTL+TBB in C, D and E: * P<0.05; ** P<0.01.